Daniel is a molecular biologist with a special interest in biochemistry of malaria parasites. He graduated with PhD in Molecular Medicine in July 2015 at Jomo Kenyatta University of Agriculture and Technology (JKUAT), Nairobi Kenya, funded by WHO/TDR, NACOSTI and Cambridge Africa Alborada Fund. His MSc and PhD research focused on selection and identification of molecular markers associated with antimalarial drugs piperaquine and lumefantrine resistance in rodent malaria parasites Plasmodium berghei ANKA. His study mapped promising mutations in proteins that are highly credible drug transporters and targets. During his PhD training he visited Drs Oliver and Julian laboratory at the Welcome Trust Sanger Institute, U.K. He trained on transfection work using gene knockout and epitope tagging, PlasmoGEM vectors for P. berghei and their application in validating resistance markers/drug transporters/targets. He later started and continued with the P. berghei transfection work in KEMRI, Nairobi. Daniel joined the programme in June 2016 as PostDoc under the WACCBIP programme with key focus on identifying and validating Plasmodium proteins associated not only with drug resistance but also to genes of interest in malaria immunity.